NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2023 Earnings Call Transcript May 16, 2023
NRx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.14.
Operator: Good day, everyone, and welcome to NRx Pharmaceuticals’ First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please...
